ESSA Pharma Inc (EPIX)
5.82
-0.30
(-4.90%)
USD |
NASDAQ |
Apr 26, 13:02
ESSA Pharma Cash from Operations (TTM): -22.19M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -22.19M |
September 30, 2023 | -19.78M |
June 30, 2023 | -22.77M |
March 31, 2023 | -25.76M |
December 31, 2022 | -26.56M |
September 30, 2022 | -28.00M |
June 30, 2022 | -27.91M |
March 31, 2022 | -28.11M |
December 31, 2021 | -27.29M |
September 30, 2021 | -25.42M |
June 30, 2021 | -22.18M |
March 31, 2021 | -19.15M |
December 31, 2020 | -17.57M |
September 30, 2020 | -16.98M |
June 30, 2020 | -17.98M |
March 31, 2020 | -16.99M |
December 31, 2019 | -13.76M |
September 30, 2019 | -12.25M |
June 30, 2019 | -9.333M |
Date | Value |
---|---|
March 31, 2019 | -9.646M |
December 31, 2018 | -10.13M |
September 30, 2018 | -10.22M |
June 30, 2018 | -11.00M |
March 31, 2018 | -13.27M |
December 31, 2017 | -12.74M |
September 30, 2017 | -17.35M |
June 30, 2017 | -17.73M |
March 31, 2017 | -16.05M |
December 31, 2016 | -19.25M |
September 30, 2016 | -15.30M |
June 30, 2016 | -16.69M |
March 31, 2016 | -18.34M |
December 31, 2015 | -13.87M |
September 30, 2015 | -13.34M |
June 30, 2015 | -9.808M |
March 31, 2015 | -5.498M |
December 31, 2014 | -4.037M |
September 30, 2014 | -2.081M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-28.11M
Minimum
Mar 2022
-9.333M
Maximum
Jun 2019
-21.05M
Average
-22.18M
Median
Jun 2021
Cash from Operations (TTM) Benchmarks
Acasti Pharma Inc | -13.57M |
Aurinia Pharmaceuticals Inc | -33.46M |
Edesa Biotech Inc | -6.252M |
Lexaria Bioscience Corp | -5.209M |
Xenon Pharmaceuticals Inc | -145.33M |